The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting

AIDS Patient Care and STDs

Volumn 24, Issue 10, 2010, Pages 639-649

  Vreeman, Rachel C ^a,b,c   Nyandiko, Winstone M ^b,d   Ayaya, Samwel O ^b,d   Walumbe, Eunice G ^b   Marrero, David G ^a   Inui, Thomas S ^a,b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

^c REGENSTRIEF INSTITUTE   (United States)

^d MOI UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; CAREGIVER; CHILD; CHILD WELFARE; FEAR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INFANT; INTERPERSONAL COMMUNICATION; INTERVIEW; KENYA; MAJOR CLINICAL STUDY; MALE; PARENT; PARENTAL ATTITUDE; PATIENT COMPLIANCE; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SOCIAL DISCRIMINATION; SOCIAL NETWORK;

ADOLESCENT; ANTI-HIV AGENTS; CAREGIVERS; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; FEMALE; FOCUS GROUPS; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INTERVIEWS AS TOPIC; KENYA; MALE; MEDICATION ADHERENCE; PARENTS; POVERTY; SOCIAL SUPPORT; TRUTH DISCLOSURE;

EID: 77957994771     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0079     Document Type: Article

References (52)

1. Doerholt K, Duong T, Tookey P, et al. Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J 2006;25:420-426.
2. Wood E, Hogg RS, Yip B, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350×10(9) cells/L. Ann Intern Med 2003;139:810-816.
3. Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J 2003;22:56-62. (Pubitemid 36091779)
4. Hogg RS, Yip B, Kully C, et al. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ 1999;160:659-665.
5. Needham DM, Hogg RS, Yip B, O'Shaughnessy M, Schechter MT, Montaner JS. The impact of antiretroviral therapy on AIDS survival observed in a province-wide drug treatment programme. Int J STD AIDS 1998;9:370-372.
6. Nyandiko WM, Ayaya S, Nabakwe E, et al. Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr 2006;43:418-425.
7. Bracher L, Valerius NH, Rosenfeldt V, et al. Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark. Scand J Infect Dis 2007;39:799-804.
8. UNAIDS. 2006 Report on the global AIDS epidemic. The Joint United Nations Programme on HIV/AIDS (UNAIDS); 2006.
9. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-1183.
10. Boon-Yasidhi V, Kottapat U, Durier Y, et al. Diagnosis disclosure in HIV-infected Thai children. J Med Assoc Thai 2005;88(Suppl 8):S100-105.
11. Butler AM, Williams PL, Howland LC, Storm D, Hutton N, Seage GR, 3rd. Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics 2009;123:935-943.
12. Menon A, Glazebrook C, Campain N, Ngoma M. Mental health and disclosure of HIV status in Zambian adolescents with HIV infection: Implications for peer-support programs. J Acquir Immune Defic Syndr 2007;46:349-354.
13. Oberdorfer P, Puthanakit T, Louthrenoo O, Charnsil C, Sirisanthana V, Sirisanthana T. Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand. J Paediatr Child Health 2006;42:283-288.
14. Marhefka SL, Tepper VJ, Brown JL, Farley JJ. Caregiver psychosocial characteristics and children's adherence to antiretroviral therapy. AIDS Patient Care STDs 2006;20: 429-437.
15. Mellins C, Brackis-Cott E, Dolezal C, Richards A, Nicholas S, Abrams E. Patterns of HIV status disclosure to perinatally HIV-infected children and subsequent mental health outcomes. Clin Child Psychol Psych 2002;7:101-114.
16. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virusinfected children. Pediatr Infect Dis J 2004;23:1035-1041.
17. Brackis-Cott E, Mellins CA, Abrams E, Reval T, Dolezal C. Pediatric HIV medication adherence: The views of medical providers from two primary care programs. J Pediatr Health Care 2003;17:252-260.
18. Wiener L, Mellins CA, Marhefka S, Battles HB. Disclosure of an HIV diagnosis to children: History, current research, and future directions. J Dev Behav Pediatr 2007;28:155-166.
19. Gerson AC, Joyner M, Fosarelli P, et al. Disclosure of HIV diagnosis to children: when, where, why, and how. J Pediatr Health Care 2001;15:161-167.
20. Hammami N, Nostlinger C, Hoeree T, Lefevre P, Jonckheer T, Kolsteren P. Integrating adherence to highly active antiretroviral therapy into children's daily lives: A qualitative study. Pediatrics 2004;114:e591-597.
21. Myer L, Moodley K, Hendricks F, Cotton M. Healthcare providers' perspectives on discussing HIV status with infected children. J Trop Pediatr 2006;52:293-295.
22. Moodley K, Myer L, Michaels D, Cotton M. Paediatric HIV disclosure in South Africa-Caregivers' perspectives on discussing HIV with infected children. S Afr Med J 2006;96:201-204.
23. Vaz L, Corneli A, Dulyx J, et al. The process of HIV status disclosure to HIV-positive youth in Kinshasa, Democratic Republic of the Congo. AIDS Care 2008;20:842-852.
24. Bikaako-Kajura W, Luyirika E, Purcell DW, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006;10:S85-93.
25. Nabukeera-Barungi N, Kalyesubula I, Kekitiinwa A, Byakika-Tusiime J, Musoke P. Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala. Ann Trop Paediatr 2007;27:123-131.
26. Biadgilign S, Deribew A, Amberbir A, Deribe K. Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia. BMC Pediatr 2008;8:53.
27. Vaz L, Eng E, Maman S, Tshikandu T, Behets F. Telling children they have HIV: Lessons learned from findings of a qualitative study in sub-Saharan Africa. AIDS Patient Care STDs 2010;24:247-256.
28. Pequegnat W, Page B, Strauss A, et al. Qualitative inquiry: An underutilized strategy in AIDS research. In: Pequegnat W, Stover E, eds. How to Write a Successful Research Grant Application. New York: Plenum Press, 1995:97-113.
29. Miller WL, Crabtree BF. Clinical research: A multimethod typology and qualitative roadmap. In: Crabtree BF, Miller WL, eds. Doing Qualitative Research. 2nd edition. Thousand Oaks, CA: Sage Publications, 1999:6-32.
30. Sankar A, Golin C, Simoni JM, Luborsky M, Pearson C. How qualitative methods contribute to understanding combination antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2006;43(Suppl 1):S54-68.
31. Strauss A, Corbin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Newbury Park, CA: SAGE Publications, 1990.
32. Glaser B, Strauss A. The Discovery of Grounded Theory: Strategies for Qualitative Research. New York: Aldine Publishing Company, 1967.
33. Quigley F. Walking Together, Walking Far: How a U.S. and African Medical School Partnership is Winning the Fight Against HIV/AIDS. Bloomington, Indiana: Indiana University Press, 2009.
34. Einterz RM, Kimaiyo S, Mengech HN, et al. Responding to the HIV pandemic: The power of an academic medical partnership. Acad Med 2007;82:812-818.
35. -2007 Kenya AIDS Indicatory Survey. Nairobi, Kenya: Kenya Ministry of Health, 2008.
36. Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS. Factors sustaining pediatric adherence to antiretroviral therapy in western Kenya. Qual Health Res 2009;19:1716-1729.
37. Kreuger RA. Focus Groups: A Practical Guide for Applied Research, 2nd ed. Thousand Oaks, CA: Sage Publications, 1994.
38. Morgan DL, Kreuger RA. The Focus Group Kit. Thousand Oaks, CA: Sage Publications, 1998.
39. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
40. Giacomini MK, Cook DJ. Users' guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 2000;284:357-362.
41. Giacomini MK, Cook DJ. Users' guides to the medical literature: XXIII. Qualitative research in health care B. What are the results and how do they help me care for my patients? Evidence-Based Medicine Working Group. JAMA 2000;284:478-482.
42. De Baets AJ, Sifovo S, Parsons R, Pazvakavambwa IE. HIV disclosure and discussions about grief with Shona children: A comparison between health care workers and community members in Eastern Zimbabwe. Soc Sci Med 2008;66:479-491.
43. MacDonald K, Shankardass K, Kimani G, et al. An exploratory study of the knowledge, attitudes and beliefs (KAB) of adolescents in Nairobi with respect to the disclosure of HIV status." Int Conf AIDS 2004;15:11-16.
44. Abadia-Barrero CE, Larusso MD. The disclosure model versus a developmental illness experience model for children and adolescents living with HIV/AIDS in Sao Paulo, Brazil. AIDS Patient Care STDs 2006;20:36-43.
45. Moodley K, Myer L. Paediatric HIV disclosure in South Africa-Caregivers' perspectives on discussing HIV with infected children. S Afr Med J 2006;96:201-204.
46. Weiner L, Mellins C, Marhefka S, Battles H. Disclosure of an HIV diagnosis to children: History, current research, and future directions. J Dev Behav Pediatr 2007;28:155-166.
47. Menon A, Glazebrook C, Campain N, Ngoma M. Mental health and disclosure of HIV status in Zambian adolescents with HIV infection: Implications for peer-support programs. J Acquir Immune Defic Syndr 2007;26:349-354.
48. Butler A, Williams P, Howland L, Storm D, Hutton N, Seage G. Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics 2009;123:935-943.
49. Vreeman RC, Nyandiko WM, Meslin EM. Pediatric assent for a study of antiretroviral therapy dosing for children in Western Kenya: A case study in international research collaboration. J Empir Res Hum Res Ethics 2009;4:3-16.
50. Vreeman RC, Wiehe SE, Ayaya SO, Musick BS, Nyandiko WM. Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in western Kenya. J Acquir Immune Defic Syndr 2008;49:163-170.
51. Vreeman RC, Nyandiko WM, Sang E, Musick BS, Braitstein P, Wiehe SE. Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya. Confl Health 2009;3:5.
52. Disclosure of illness status to children and adolescents with HIV infection. American Academy of Pediatrics Committee on Pediatrics AIDS. Pediatrics 1999;103:164-166.